1921
Volume 98, Issue 4
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

(SP) is a leading cause of child mortality globally, killing around half a million children aged 5 years and less per year. Nasopharyngeal carriage of SP is a prerequisite to disease, and the prevalence of colonization reaches 100% within the first few years of life. Serotype prevalence varies geographically, impacting the serotype coverage of pneumococcal vaccines, and serotype prevalence data are limited from large regions of the world, including sub-Saharan Africa. We enrolled 323 unvaccinated children, aged 4–7 years from coastal Kenya and obtained nasopharyngeal swab samples before and after vaccination with the 10-valent pneumococcal vaccine. Vaccination did not reduce the overall prevalence of pneumococcal carriage in our cohort, with 65 (20%) children colonized before vaccination and 63 (19.4%) colonized postvaccination. However, the prevalence of vaccine-included serotypes (vaccine strains) declined from 43% to 19% of positive swabs, whereas non-vaccine serotypes increased from 46% to 73%. This study contributes to the few data available regarding pneumococcal carriage and serotype prevalence in Kenya and is in concordance with reports of dynamic serotype replacement, driven by vaccine pressure.

Loading

Article metrics loading...

The graphs shown below represent data from March 2017
/content/journals/10.4269/ajtmh.16-0813
2018-02-26
2019-05-27
Loading full text...

Full text loading...

/deliver/fulltext/14761645/98/4/tpmd160813.html?itemId=/content/journals/10.4269/ajtmh.16-0813&mimeType=html&fmt=ahah

References

  1. International Vaccine Access Center JHUBSoPH 2017. The Evidence Base for Pneumococcal Conjugate Vaccines (PCVs): Data for Decision-Making around PCV Use in Childhood. Available at: http://www.jhsph.edu/research/centers-and-institutes/ivac/resources/PCVEvidenceBase-Jan2017.pdf. Accessed July 20, 2017.
  2. World Health Organization 2007. Pneumococcal conjugate vaccine for childhood immunization—WHO position paper. Wkly Epidemiol Rec 12: 93104. [Google Scholar]
  3. O’Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall N, Lee E, Mulholland K, Levine OS, Cherian T, 2009. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 374: 893902. [Google Scholar]
  4. Gray BM, Turner ME, Dillon HC, Jr 1982. Epidemiologic studies of Streptococcus pneumoniae in infants. The effects of season and age on pneumococcal acquisition and carriage in the first 24 months of life. Am J Epidemiol 116: 692703. [Google Scholar]
  5. Bogaert D, de Groot R, Hermans PWM, 2004. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis 4: 144154. [Google Scholar]
  6. Mehta S, 2010. Developing the right pneumococcal vaccine for the time and place. Am J Trop Med Hyg 83: 449450. [Google Scholar]
  7. Hausdorff WP, Bryant J, Paradiso PR, Siber GR, 2000. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin Infect Dis 30: 100121. [Google Scholar]
  8. Hausdorff WP, Feikin DR, Klugman KP, 2005. Epidemiological differences among pneumococcal serotypes. Lancet Infect Dis 5: 8393. [Google Scholar]
  9. Johnson HL, Deloria-Knoll M, Levine OS, Stoszek SK, Freimanis Hance L, Reithinger R, Muenz LR, O’Brien KL, 2010. Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project. PLoS Med 7: e1000348. [Google Scholar]
  10. Wellcome Trust, 2011. The Pneumococcal Conjugate Vaccine Protects Kenyan Children. Available at: http://kemri-wellcome.org/news/the-pneumococcal-conjugate-vaccine-protects-kenyan-children/. Accessed July 18, 2017.
  11. LaBeaud AD, 2015. Parasitism in children aged three years and under: relationship between infection and growth in rural coastal Kenya. PLoS Negl Trop Dis 9: e0003721. [Google Scholar]
  12. Malhotra I, McKibben M, Mungai P, McKibben E, Wang X, Sutherland LJ, Muchiri EM, King CH, King CL, LaBeaud AD, 2015. Effect of antenatal parasitic infections on anti-vaccine IgG levels in children: a prospective birth cohort study in Kenya. PLoS Negl Trop Dis 9: e0003466. [Google Scholar]
  13. Nayakwadi Singer M, 2017. Pneumococcal vaccine response after exposure to parasites in utero, in infancy, or mid-childhood. Pediatrics 139: pii: e20162781. [Google Scholar]
  14. United States Census Bureau, 2014. Population Estimates. Available at: https://www.census.gov/population/international/data/idb/informationGateway.php. Accessed July 18, 2017.
  15. WHO and UNICEF 2015. Estimates of National Immunization Coverage—Kenya. Available at: http://www.who.int/immunization/monitoring_surveillance/data/ken.pdf. Accessed July 18, 2017.
  16. Kenya National Bureau of Statistics, Ministry of Health/Kenya, National AIDS Control Council/Kenya, Kenya Medical Research Institute, National Council for Population, Development/Kenya 2015. Kenya Demographic and Health Survey 2014. Rockville, MD: Kenyan National Bureau of Statistics.
  17. O’Brien KL, 2001. Evaluation of a medium (STGG) for transport and optimal recovery of Streptococcus pneumoniae from nasopharyngeal secretions collected during field studies. J Clin Microbiol 39: 10211024. [Google Scholar]
  18. Lim DV, Morales WJ, Walsh AF, 1987. Lim group B Strep Broth and coagglutination for rapid identification of group B streptococci in preterm pregnant women. J Clin Microbiol 25: 452453. [Google Scholar]
  19. Centers for Disease Control and Prevention 2014. PCR Deduction of Pneumococcal Serotypes. Available at: http://www.cdc.gov/streplab/pcr.html. Accessed December 1, 2014.
  20. Hammitt LL, 2014. Population effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and non-typeable Haemophilus influenzae in Kilifi, Kenya: findings from cross-sectional carriage studies. Lancet Glob Health 2: e397e405. [Google Scholar]
  21. Usuf E, Bottomley C, Adegbola RA, Hall A, 2014. Pneumococcal carriage in sub-Saharan Africa—a systematic review. PLoS One 9: e85001. [Google Scholar]
  22. System; KHaDS 2015. The Pneumoccocal Conjugate Vaccine Impact Study. Available at: http://www.kemri-wellcome.org/index.php/en/studies_inner/75. Accessed July 20, 2017.
  23. Feikin DR, Kagucia EW, Loo JD, Link-Gelles R, Puhan MA, Cherian T, Levine OS, Whitney CG, O’Brien KL, Moore MR, 2013. Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites. PLoS Med 10: e1001517. [Google Scholar]
  24. Hanage WP, 2007. Serotype replacement in invasive pneumococcal disease: where do we go from here? J Infect Dis 196: 12821284. [Google Scholar]
  25. Pelton SI, Loughlin AM, Marchant CD, 2004. Seven valent pneumococcal conjugate vaccine immunization in two Boston communities: changes in serotypes and antimicrobial susceptibility among Streptococcus pneumoniae isolates. Pediatr Infect Dis J 23: 10151022. [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.16-0813
Loading
/content/journals/10.4269/ajtmh.16-0813
Loading

Data & Media loading...

  • Received : 17 Oct 2016
  • Accepted : 20 Dec 2017
  • Published online : 26 Feb 2018

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error